Gregory Renza
Stock Analyst at Truist Securities
(3.38)
# 936
Out of 5,149 analysts
255
Total ratings
41.59%
Success rate
5.7%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines AG | Maintains: Buy | $400 → $412 | $297.04 | +38.70% | 4 | Feb 27, 2026 | |
| GILD Gilead Sciences | Maintains: Buy | $145 → $152 | $147.83 | +2.82% | 3 | Feb 11, 2026 | |
| CGON CG Oncology | Maintains: Buy | $66 → $75 | $60.55 | +23.86% | 6 | Feb 10, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $820 → $818 | $766.66 | +6.70% | 3 | Feb 2, 2026 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $41 → $40 | $29.32 | +36.43% | 13 | Jan 8, 2026 | |
| AMGN Amgen | Maintains: Hold | $318 → $319 | $377.00 | -15.38% | 19 | Jan 8, 2026 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $59 → $60 | $34.31 | +74.88% | 14 | Jan 6, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $32 → $38 | $28.48 | +33.43% | 8 | Dec 24, 2025 | |
| FULC Fulcrum Therapeutics | Maintains: Buy | $14 → $18 | $7.87 | +128.72% | 5 | Dec 11, 2025 | |
| CATX Perspective Therapeutics | Assumes: Buy | $8 → $12 | $5.17 | +132.11% | 7 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $23 → $30 | $15.81 | +89.75% | 12 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $12.02 | +141.26% | 10 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $4.36 | +152.29% | 7 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $140 | $100.22 | +39.69% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.93 | +207.69% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $10 | $5.50 | +81.82% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $21.59 | +136.26% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $140 | $111.10 | +26.01% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $45 → $50 | $40.74 | +22.73% | 11 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $26 | $22.50 | +15.56% | 16 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $4.05 | +97.53% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $5 | $1.68 | +197.62% | 11 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $182 → $172 | $186.67 | -7.86% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $113 → $38 | $55.83 | -32.83% | 14 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $12 | $6.91 | +73.66% | 6 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $14 | $5.68 | +146.48% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $18 | $22.10 | -18.55% | 11 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $68 → $48 | $1.33 | +3,509.02% | 4 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $110 → $20 | $5.12 | +290.63% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $16 | $0.96 | +1,566.84% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $2,160 → $180 | $18.85 | +854.91% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $100 → $80 | $0.85 | +9,322.85% | 5 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $105 → $30 | $0.15 | +19,873.37% | 3 | Jun 2, 2020 |
BeOne Medicines AG
Feb 27, 2026
Maintains: Buy
Price Target: $400 → $412
Current: $297.04
Upside: +38.70%
Gilead Sciences
Feb 11, 2026
Maintains: Buy
Price Target: $145 → $152
Current: $147.83
Upside: +2.82%
CG Oncology
Feb 10, 2026
Maintains: Buy
Price Target: $66 → $75
Current: $60.55
Upside: +23.86%
Regeneron Pharmaceuticals
Feb 2, 2026
Maintains: Buy
Price Target: $820 → $818
Current: $766.66
Upside: +6.70%
Viridian Therapeutics
Jan 8, 2026
Maintains: Buy
Price Target: $41 → $40
Current: $29.32
Upside: +36.43%
Amgen
Jan 8, 2026
Maintains: Hold
Price Target: $318 → $319
Current: $377.00
Upside: -15.38%
IDEAYA Biosciences
Jan 6, 2026
Maintains: Buy
Price Target: $59 → $60
Current: $34.31
Upside: +74.88%
Agios Pharmaceuticals
Dec 24, 2025
Maintains: Buy
Price Target: $32 → $38
Current: $28.48
Upside: +33.43%
Fulcrum Therapeutics
Dec 11, 2025
Maintains: Buy
Price Target: $14 → $18
Current: $7.87
Upside: +128.72%
Perspective Therapeutics
Nov 24, 2025
Assumes: Buy
Price Target: $8 → $12
Current: $5.17
Upside: +132.11%
Nov 24, 2025
Assumes: Buy
Price Target: $23 → $30
Current: $15.81
Upside: +89.75%
Nov 24, 2025
Initiates: Buy
Price Target: $29
Current: $12.02
Upside: +141.26%
Nov 24, 2025
Initiates: Buy
Price Target: $11
Current: $4.36
Upside: +152.29%
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $100.22
Upside: +39.69%
Nov 24, 2025
Initiates: Buy
Price Target: $9
Current: $2.93
Upside: +207.69%
Nov 24, 2025
Initiates: Hold
Price Target: $10
Current: $5.50
Upside: +81.82%
Nov 24, 2025
Initiates: Buy
Price Target: $51
Current: $21.59
Upside: +136.26%
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $111.10
Upside: +26.01%
Jul 8, 2025
Downgrades: Sector Perform
Price Target: $45 → $50
Current: $40.74
Upside: +22.73%
May 19, 2025
Reiterates: Outperform
Price Target: $26
Current: $22.50
Upside: +15.56%
May 15, 2025
Reiterates: Outperform
Price Target: $8
Current: $4.05
Upside: +97.53%
May 14, 2025
Reiterates: Sector Perform
Price Target: $5
Current: $1.68
Upside: +197.62%
May 7, 2025
Maintains: Outperform
Price Target: $182 → $172
Current: $186.67
Upside: -7.86%
Apr 16, 2025
Maintains: Sector Perform
Price Target: $113 → $38
Current: $55.83
Upside: -32.83%
Mar 26, 2025
Reiterates: Outperform
Price Target: $12
Current: $6.91
Upside: +73.66%
Mar 21, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $5.68
Upside: +146.48%
Jan 14, 2025
Reiterates: Sector Perform
Price Target: $18
Current: $22.10
Upside: -18.55%
Jan 9, 2025
Maintains: Outperform
Price Target: $68 → $48
Current: $1.33
Upside: +3,509.02%
Nov 5, 2024
Downgrades: Sector Perform
Price Target: $110 → $20
Current: $5.12
Upside: +290.63%
Aug 14, 2024
Reiterates: Outperform
Price Target: $16
Current: $0.96
Upside: +1,566.84%
Jun 27, 2023
Downgrades: Sector Perform
Price Target: $2,160 → $180
Current: $18.85
Upside: +854.91%
Mar 16, 2022
Maintains: Sector Perform
Price Target: $100 → $80
Current: $0.85
Upside: +9,322.85%
Jun 2, 2020
Downgrades: Sector Perform
Price Target: $105 → $30
Current: $0.15
Upside: +19,873.37%